Identification of Loss of Function Mutations in Human Genes Encoding RIG-I and MDA5
Taeko Shigemoto,Maiko Kageyama,Reiko Hirai,JiPing Zheng,Mitsutoshi Yoneyama,Takashi Fujita
DOI: https://doi.org/10.1074/jbc.m809449200
IF: 5.485
2009-01-01
Journal of Biological Chemistry
Abstract:Retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) are essential for detecting viral RNA and triggering antiviral responses, including production of type I interferon. We analyzed the phenotype of non-synonymous mutants of human RIG-I and MDA5 reported in databases by functional complementation in cell cultures. Of seven missense mutations of RIG-I, S183I, which occurs within the second caspase recruitment domain repeat, inactivated this domain and conferred a dominant inhibitory function. Of 10 mutants of MDA5, two exhibited loss of function. A nonsense mutation, E627*, resulted in deletion of the C-terminal region and double-stranded RNA (dsRNA) binding activity. Another loss of function mutation, I923V, which occurs within the C-terminal domain, did not affect dsRNA binding activity, suggesting a novel and essential role for this residue in the signaling. Remarkably, these mutations are implicated in resistance to type I diabetes. However, the A946T mutation of MDA5, which has been implicated in type I diabetes by previous genetic analyses, affected neither dsRNA binding nor IFN gene activation. These results provide new insights into the structure-function relationship of RIG-I-like receptors as well as into human RIG-I-like receptor polymorphisms, antiviral innate immunity, and autoimmune diseases. Retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) are essential for detecting viral RNA and triggering antiviral responses, including production of type I interferon. We analyzed the phenotype of non-synonymous mutants of human RIG-I and MDA5 reported in databases by functional complementation in cell cultures. Of seven missense mutations of RIG-I, S183I, which occurs within the second caspase recruitment domain repeat, inactivated this domain and conferred a dominant inhibitory function. Of 10 mutants of MDA5, two exhibited loss of function. A nonsense mutation, E627*, resulted in deletion of the C-terminal region and double-stranded RNA (dsRNA) binding activity. Another loss of function mutation, I923V, which occurs within the C-terminal domain, did not affect dsRNA binding activity, suggesting a novel and essential role for this residue in the signaling. Remarkably, these mutations are implicated in resistance to type I diabetes. However, the A946T mutation of MDA5, which has been implicated in type I diabetes by previous genetic analyses, affected neither dsRNA binding nor IFN gene activation. These results provide new insights into the structure-function relationship of RIG-I-like receptors as well as into human RIG-I-like receptor polymorphisms, antiviral innate immunity, and autoimmune diseases. Innate and adaptive immune systems constitute the defense against infections by pathogens. Immediately after an infection occurs, various cells in the body sense the virus and initiate antiviral responses in which type I IFN 2The abbreviations used are: IFN, interferon; IPS-1, IFN-β promoter stimulator 1; RIG-I, retinoic acid-inducible gene I; MDA5, melanoma differentiation-associated gene 5; LGP2, laboratory of genetics and physiology 2; TLR, Toll-like receptor; RLR, RIG-I-like receptor; PAMP, pathogen-associated molecular pattern; CARD, caspase recruitment domain; CTD, C-terminal domain; SNP, single nucleotide polymorphisms; nsSNP, non-synonymous SNP; MEF, mouse embryonic fibroblast; SeV, Sendai virus; T1D, type I diabetes; dsRNA, double-stranded RNA; ssRNA, single-stranded RNA; EMSA, electrophoretic mobility shift assay; WT, wild type. plays a critical role, both in viral inhibition and in the subsequent adaptive immune response (1Samuel C.E. Clin. Microbiol. Rev. 2001; 14: 778-809Crossref PubMed Scopus (2151) Google Scholar). The production of IFN is initiated when sensor molecules such as Toll-like receptors (TLRs) and RLRs detect virus-associated molecules. TLRs detect pathogen-associated molecular patterns (PAMPs) at the cell surface or in the endosome in immune cells such as dendritic cells and macrophages (2Akira S. Uematsu S. Takeuchi O. Cell. 2006; 124: 783-801Abstract Full Text Full Text PDF PubMed Scopus (8787) Google Scholar). RLRs sense viral RNA in the cytoplasm of most cell types and induce antiviral responses, including the activation of IFN genes (3Yoneyama M. Kikuchi M. Natsukawa T. Shinobu N. Imaizumi T. Miyagishi M. Taira K. Akira S. Fujita T. Nat. Immun. 2004; 5: 730-737Crossref Scopus (3121) Google Scholar). RLRs include RIG-I, MDA5, and laboratory of genetics and physiology 2 (LGP2). It is proposed that RLRs sense and activate antiviral signals through the coordination of their functional domains (4Yoneyama M. Fujita T. Immunity. 2008; 29: 178-181Abstract Full Text Full Text PDF PubMed Scopus (210) Google Scholar). The N-terminal region of RIG-I and MDA5 is characterized by two repeats of CARD and functions as an activation domain (3Yoneyama M. Kikuchi M. Natsukawa T. Shinobu N. Imaizumi T. Miyagishi M. Taira K. Akira S. Fujita T. Nat. Immun. 2004; 5: 730-737Crossref Scopus (3121) Google Scholar). This domain is responsible for the transduction of signals downstream to IFN-β promoter stimulator 1 (IPS-1) (also known as MAVS, VISA, and Cardif). The primary sequence of the CTD, consisting of ∼140 amino acids, is conserved among RLRs. The CTD of RIG-I functions as a viral RNA-sensing domain as revealed by biochemical and structural analyses (5Cui S. Eisenacher K. Kirchhofer A. Brzozka K. Lammens A. Lammens K. Fujita T. Conzelmann K.K. Krug A. Hopfner K.P. Mol. Cell. 2008; 29: 169-179Abstract Full Text Full Text PDF PubMed Scopus (430) Google Scholar, 6Takahasi K. Yoneyama M. Nishihori T. Hirai R. Kumeta H. Narita R. Gale Jr., M. Inagaki F. Fujita T. Mol. Cell. 2008; 29: 428-440Abstract Full Text Full Text PDF PubMed Scopus (392) Google Scholar). Both dsRNA and 5′-ppp-ssRNA, which are generated in the cytoplasm of virus-infected cells, are recognized by a basic cleft structure of RIG-I CTD. In addition to its RNA recognition function, the CTD of RIG-I and LGP2 functions as a repression domain through interaction with the activation domain. The repression domain is responsible for keeping RIG-I inactive in non-stimulated cells (3Yoneyama M. Kikuchi M. Natsukawa T. Shinobu N. Imaizumi T. Miyagishi M. Taira K. Akira S. Fujita T. Nat. Immun. 2004; 5: 730-737Crossref Scopus (3121) Google Scholar, 7Saito T. Hirai R. Loo Y.M. Owen D. Johnson C.L. Sinha S.C. Akira S. Fujita T. Gale Jr., M. Proc. Natl. Acad. Sci. U. S. A. 2007; 104: 582-587Crossref PubMed Scopus (583) Google Scholar). The helicase domain, with DEXD/H box-containing RNA helicase motifs, is the largest domain found in RLRs. Once dsRNA or 5′-ppp-ssRNA is recognized by the CTD, the helicase domain causes structural changes to release the activation domain. ATP binding and/or its hydrolysis is essential for the conformational change because Walker's ATP-binding site within the helicase domain is essential for signaling by RIG-I and MDA5. Analyses of knock-out mice have revealed that RIG-I and MDA5 recognize distinct RNA viruses (8Gitlin L. Barchet W. Gilfillan S. Cella M. Beutler B. Flavell R.A. Diamond M.S. Colonna M. Proc. Natl. Acad. Sci. U. S. A. 2006; 103: 8459-8464Crossref PubMed Scopus (911) Google Scholar, 9Kato H. Takeuchi O. Sato S. Yoneyama M. Yamamoto M. Matsui K. Uematsu S. Jung A. Kawai T. Ishii K.J. Yamaguchi O. Otsu K. Tsujimura T. Koh C.S. Reis e Sousa C. Matsuura Y. Fujita T. Akira S. Nature. 2006; 441: 101-105Crossref PubMed Scopus (2905) Google Scholar). Picornaviruses are detected by MDA5, but many other viruses such as influenza A, Sendai, vesicular stomatitis, and Japanese encephalitis are detected by RIG-I. The difference is based on the distinct non-self RNA patterns generated by viruses, as demonstrated by the finding that RIG-I is selectively activated by dsRNA or 5′-ppp ssRNA, whereas MDA5 is activated by long dsRNA (10Hornung V. Ellegast J. Kim S. Brzozka K. Jung A. Kato H. Poeck H. Akira S. Conzelmann K.K. Schlee M. Endres S. Hartmann G. Science. 2006; 314: 994-997Crossref PubMed Scopus (1894) Google Scholar, 11Kato H. Takeuchi O. Mikamo-Satoh E. Hirai R. Kawai T. Matsushita K. Hiiragi A. Dermody T.S. Fujita T. Akira S. J. Exp. Med. 2008; 205: 1601-1610Crossref PubMed Scopus (1160) Google Scholar, 12Pichlmair A. Schulz O. Tan C.P. Naslund T.I. Liljestrom P. Weber F. Reis e Sousa C. Science. 2006; 314: 997-1001Crossref PubMed Scopus (1771) Google Scholar). Single nucleotide polymorphisms (SNPs) of the human RIG-I and MDA5 genes including several non-synonymous SNPs (nsSNPs), which potentially alter the function of the proteins encoded, are reported in databases. In this report, we investigated the functions of nsSNPs of RIG-I and MDA5 by functional complementation using respective knock-out cells. We identified loss of function mutations of RIG-I and MDA5. Notably, two MDA5 mutations, E627* and I923V, recently reported to have a strong association with resistance to T1D (13Nejentsev S. Walker N. Riches D. Egholm M. Todd J.A. Science. March 5, 2009; 10.1126/science.1167728PubMed Google Scholar), were severely inactive. The results suggest a novel molecular mechanism for the activation of RLRs and will contribute to our understanding of the functional effects of RLR polymorphisms and the critical relationship between RLR nsSNPs and diseases. Cells, DNA Transfection, and Preparation of Cell Extracts—L929 cells were maintained in minimum essential medium Eagle (Sigma) with 5% fetal bovine serum and penicillin/streptomycin. Mouse embryonic fibroblasts (MEFs) were obtained from Dr. S. Akira (Osaka University). MEFs and 293T cells were maintained in Dulbecco's modified Eagle's medium with 10% fetal bovine serum and penicillin/streptomycin. L929 cells were transiently transfected with the DEAE-dextran method. MEFs and 293T cells were transiently transfected by FuGENE 6 (Roche Applied Science). For the preparation of cell extracts, cells were lysed with lysis buffer (50 mm Tris-HCl, pH 7.5, 150 mm NaCl, 1 mm EDTA, 1% Nonidet P-40, 0.1 mg/ml leupeptin, 1 mm phenylmethylsulfonyl fluoride, and 1 mm sodium orthovanadate) and centrifuged at 245,000 × g for 10 min. The supernatant was used for SDS-PAGE and electrophoretic mobility shift assays (EMSAs). Oligonucleotides—Oligonucleotides (800 bp) corresponding to the coding sequence of green fluorescent protein were amplified by PCR using T7-primer (5′-CGTAATACGACTCACTATAGGGGATATCAGCAAAGGAGAAGAACTTTT-3′) and T3-primer (5′-GCAATTAACCCTCACTAAAGGGAGGCCTAGGGAGAAGACAGTGAGCTC-3′). Long dsRNA (ds800) was prepared by annealing complementary strands separately synthesized by in vitro transcription using the AmpliScribe T7 flash transcription kit (EPICENTRE Biotechnologies) and the AmpliScribe SP6 high yield transcription kit (EPICENTRE Biotechnologies). The annealed dsRNA was treated with S1 nuclease (Takara Bio) to generate a blunt end and alkaline phosphatase (Takara Bio) to remove 5′-phosphate. 32P-ds800 was prepared by labeling the 800-bp dsRNA using T4 polynucleotide kinase and [γ-32P]ATP. Reporter Assay—MEFs were transfected with p55-C1Bluc, pRLtK, and expression plasmids for RIG-I mutants or MDA5 mutants. Cells were split into two aliquots, stimulated with RNA (5′-pppGG25) (6Takahasi K. Yoneyama M. Nishihori T. Hirai R. Kumeta H. Narita R. Gale Jr., M. Inagaki F. Fujita T. Mol. Cell. 2008; 29: 428-440Abstract Full Text Full Text PDF PubMed Scopus (392) Google Scholar) or poly(I-C) transfection or Sendai virus (SeV) infection for 12 h, and harvested at 48 h after DNA transfection. L929 cells were transfected similar to MEFs but were stimulated by Newcastle disease virus infection. The infections were performed as described previously (14Yoneyama M. Kikuchi M. Matsumoto K. Imaizumi T. Miyagishi M. Taira K. Foy E. Loo Y.M. Gale Jr., M. Akira S. Yonehara S. Kato A. Fujita T. J. Immunol. 2005; 175: 2851-2858Crossref PubMed Scopus (1290) Google Scholar). The RNA transfection and poly(I-C) transfection were performed using Lipofectamine™ RNAiMAX (Invitrogen). The luciferase assay was performed with a Dual-Luciferase reporter assay system (Promega). Luciferase activity was normalized using Renilla luciferase activity (pRLtk) as a reference. Quantitative PCR Assay—Quantitative PCR was performed as described previously (3Yoneyama M. Kikuchi M. Natsukawa T. Shinobu N. Imaizumi T. Miyagishi M. Taira K. Akira S. Fujita T. Nat. Immun. 2004; 5: 730-737Crossref Scopus (3121) Google Scholar). Plasmid Constructs—p-55C1Bluc and pRLtk, pEF-FLAG-RIG-I, pEF-FLAG-RIG-ICARD, pEF-FLAG-MDA5, and pEF-FLAG-MDA5CARD were described previously (14Yoneyama M. Kikuchi M. Matsumoto K. Imaizumi T. Miyagishi M. Taira K. Foy E. Loo Y.M. Gale Jr., M. Akira S. Yonehara S. Kato A. Fujita T. J. Immunol. 2005; 175: 2851-2858Crossref PubMed Scopus (1290) Google Scholar). Data on SNPs for RIG-I and MDA5 were obtained from the NCBI (www.ncbi.nlm.nih.gov) and HapMap databases. The expression plasmids for RIG-I mutants (pEF-FLAG-RIG-IR7C, pEF-FLAG-RIG-IS144F, pEF-FLAG-RIG-IS183I, pEF-FLAG-RIG-IT260P, pEF-FLAG-RIG-II406T, pEF-FLAG-RIG-ID580E, pEF-FLAG-RIG-IF789L, and pEF-FLAG-RIG-ICARDS183I) and MDA5 mutants (pEF-FLAG-MDA5T260S, pEF-FLAG-MDA5L274I, pEF-FLAG-MDA5K351E, pEF-FLAG-MDA5I442V, pEF-FLAG-MDA5H460R, pEF-FLAG-MDA5E627*, pEF-FLAG-MDA5H843R, pEF-FLAG-MDA5I923V, pEF-FLAG-MDA5A946T, and pEF-FLAG-MDA5D1014E) were generated using a GeneEditor in vitro site-directed mutagenesis system (Promega). The mutations were confirmed by sequencing. Antibodies and Immunoblotting—The anti-FLAG (M2; Sigma) antibody is a commercial product. SDS-PAGE and immunoblotting were performed as described previously (14Yoneyama M. Kikuchi M. Matsumoto K. Imaizumi T. Miyagishi M. Taira K. Foy E. Loo Y.M. Gale Jr., M. Akira S. Yonehara S. Kato A. Fujita T. J. Immunol. 2005; 175: 2851-2858Crossref PubMed Scopus (1290) Google Scholar). EMSA—293T cells (1 × 106/6-cm dish) were transfected with 1 μg of expression vector. At 24 h after transfection, cell extract was prepared and mixed with anti-FLAG beads (Sigma) to adsorb FLAG-tagged proteins. The beads were washed, and bound protein was eluted with FLAG peptide (Sigma). The method of EMSA was described previously (6Takahasi K. Yoneyama M. Nishihori T. Hirai R. Kumeta H. Narita R. Gale Jr., M. Inagaki F. Fujita T. Mol. Cell. 2008; 29: 428-440Abstract Full Text Full Text PDF PubMed Scopus (392) Google Scholar). Construction of RIG-I Mutants and Their Biological Activities in MEFs Derived from RIG-I Knock-out Mice—nsSNPs were selected from nucleotide sequence polymorphisms of human RIG-I reported in databases and introduced into the RIG-I expression vector by site-directed mutagenesis. Domain structure and locations of the mutations are indicated in Fig. 1A. In RIG-I–/– MEFs transiently transfected with these vectors, the wild type and seven human RIG-I mutants were expressed at comparable levels (Fig. 1B). These results indicate that none of the amino acid substitutions significantly affect the synthesis and/or stability of RIG-I. The signaling function of the mutants was analyzed by temporarily complementing the function of RIG-I in RIG-I–/– MEFs using a virus-responsive luciferase reporter gene (Fig. 2A). Although the transfection of 5′-pppRNA did not activate the reporter gene significantly in RIG-I–/– MEFs (Fig. 2A, Vector), the ectopic expression of WT RIG-I restored the responsiveness to the ligand. All the mutant constructs exhibited functional complementation except the R7C, S144F, and S183I mutants, which exhibited a reduced response to 5′-pppRNA, particularly the S183I mutant, which exhibited a severe defect. Because the activity of S144F was not reproducible, we did not investigate this mutant further. It has been shown that RIG-I senses SeV and activates the IFN promoter. Therefore, the ability of the mutants to respond to this viral inducer was tested (Fig. 2B). SeV efficiently activated the reporter gene when WT RIG-I was expressed; however, S183I was virtually inactive and R7C exhibited partial activity. Other mutants sensed the virus as efficiently as the WT. We further confirmed the effect of the R7C and S183I mutations by monitoring the expression of endogenous mouse IFN-β mRNA (Fig. 2C). The results clearly demonstrate that S183I is barely active and that R7C is partially active. The above results strongly suggest that Ser-183 is critical for RIG-I to sense transfected 5′-pppRNA as well as SeV-derived PAMPs. Ser-183 resides within the second CARD, and this prompted us to explore the impact of the S183I substitution on the signaling function of the isolated RIG-I CARD. Unlike that of the full-length RIG-I, overexpression of the truncated RIG-I (1–229), which encompasses the two repeats of CARD, constitutively activated the reporter p-55C1B without a viral stimulus (Fig. 3A). However, RIG-I (1–229) with S183I failed to activate the reporter gene. In these cells, levels of RIG-I (1–229) with or without the S183I mutation were comparable, suggesting that Ser-183 is critical for the signaling function but does not affect protein levels of RIG-I CARD (Fig. 3B). It was reported that human RIG-I undergoes ubiquitination at Lys-172 in the second CARD, and this process is essential for RIG-I signaling (15Gack M.U. Shin Y.C. Joo C.H. Urano T. Liang C. Sun L. Takeuchi O. Akira S. Chen Z. Inoue S. Jung J.U. Nature. 2007; 446: 916-920Crossref PubMed Scopus (1206) Google Scholar). To compare the mutation at Ser-183, we generated a K172R mutant and tested its activity (Fig. 3, C and D). Surprisingly, the mutant exhibited virus-induced signaling activity comparable with the WT, suggesting that the ubiquitination of Lys-172 plays a minor role in the regulation of RIG-I and that the phenotype of the S183I mutant is unlikely due to a failure of ubiquitination.FIGURE 2Functional analysis of RIG-I nsSNP mutants. A and B, RIG-I–/– MEF cells were transiently transfected with p-55CIBluc together with empty vector (Vector) or the indicated constructs. The cells were subjected to a Dual-Luciferase assay after stimulation with 5′-ppp-ssRNA (12 h) (A) or SeV (12 h) (B). The relative firefly luciferase activity, normalized to the Renilla luciferase activity, is shown. Error bars show the SDs for triplicate transfections. mock, mock-treated. C, RIG-I–/– MEFs were transfected with empty vector (Vector) or expression vectors for WT RIG-I or mutants as indicated (the total amount of plasmid was kept at 6μgby adding empty vector). To observe the dose response, cells were transfected with 3 or 6 μg of the expression plasmid. Cells were mock-treated or transfected with 5′-ppp-ssRNA for 12 h, and IFN-β mRNA was quantified by quantitative PCR by using the Applied Biosystems primer set for mouse interferon-β1: Mm00439546_S1.View Large Image Figure ViewerDownload Hi-res image Download (PPT)FIGURE 3Characterization of RIG-I S183I. A, RIG-I–/– MEF cells were transfected with reporter genes together with empty vector (Vector) or plasmid expressing FLAG-tagged WT RIG-I, RIG-I CARD (the N-terminal region, amino acid 1–229), or RIG-I CARD S183I. After transfection (24 h), the cells were subjected to a Dual-Luciferase assay. Error bars show the S.D. values for triplicate transfections. B, each protein expressed in RIG-I–/– MEF cells was detected by immunoblotting using an anti-FLAG antibody. RIG-I full, full-length RIG-I. C, reporter assay of the K172R mutant was performed as in Fig. 2B. D, protein levels were determined by immunoblotting. RIG-I K172R and WT RIG-I were expressed at comparable levels. E, empty vector or expression vectors for full-length RIG-I with the T55I or S183I mutation were introduced into L929 cells (the total amount of plasmid was kept at 9 μg by adding empty vector) and infected with Newcastle disease virus, and reporter activity was analyzed as in panel A. To observe the dose response, cells received 1, 5, or 9 μg of the expression plasmid for T55I and S183I as indicated. NDV, Newcastle disease virus.View Large Image Figure ViewerDownload Hi-res image Download (PPT) It is known that human RIG-I with the amino acid substitution T55I acts as a dominant inhibitor (7Saito T. Hirai R. Loo Y.M. Owen D. Johnson C.L. Sinha S.C. Akira S. Fujita T. Gale Jr., M. Proc. Natl. Acad. Sci. U. S. A. 2007; 104: 582-587Crossref PubMed Scopus (583) Google Scholar). This mutation within the first CARD inactivates the signaling function of the isolated tandem CARDs. We next tested whether RIG-I S183I exhibits a dominant negative phenotype. L929 cells were transfected with control vector or RIG-I mutants and then activated by infection of Newcastle disease virus. Cells transfected with the vector exhibited IFN promoter activity due to endogenous RIG-I (Fig. 3E). Expression of T55I as well as S183I significantly reduced the promoter activity in a dose-dependent manner, suggesting that S183I causes a dominant negative phenotype similar to T55I. Construction of MDA5 Mutants and Their Biological Activities in MEFs Derived from MDA5 Knock-out Mouse—Next, the biological activity of human MDA5 mutants was analyzed similarly using MDA5-deficient MEFs. Ten nsSNPs including A946T identified in familial T1D (16Smyth D.J. Cooper J.D. Bailey R. Field S. Burren O. Smink L.J. Guja C. Ionescu-Tirgoviste C. Widmer B. Dunger D.B. Savage D.A. Walker N.M. Clayton D.G. Todd J.A. Nat. Genet. 2006; 38: 617-619Crossref PubMed Scopus (531) Google Scholar) were introduced into the MDA5 expression vector (Fig. 4A). The wild type and mutants were expressed in MDA5–/– MEFs at comparable levels (Fig. 4B), showing that the mutations, including the E627* truncation, did not affect MDA5 protein levels. The biological activity of the mutants was assayed similarly to that of the RIG-I mutants. As a MDA5 agonist, a commercial poly(I-C) with an average length of 2 kbp was used, which selectively activates MDA5 (6Takahasi K. Yoneyama M. Nishihori T. Hirai R. Kumeta H. Narita R. Gale Jr., M. Inagaki F. Fujita T. Mol. Cell. 2008; 29: 428-440Abstract Full Text Full Text PDF PubMed Scopus (392) Google Scholar, 11Kato H. Takeuchi O. Mikamo-Satoh E. Hirai R. Kawai T. Matsushita K. Hiiragi A. Dermody T.S. Fujita T. Akira S. J. Exp. Med. 2008; 205: 1601-1610Crossref PubMed Scopus (1160) Google Scholar). Wild-type MDA5 clearly conferred responsiveness to the poly(I-C) (Fig. 5). Eight MDA5 mutants, including A946T, which was implicated in human T1D (16Smyth D.J. Cooper J.D. Bailey R. Field S. Burren O. Smink L.J. Guja C. Ionescu-Tirgoviste C. Widmer B. Dunger D.B. Savage D.A. Walker N.M. Clayton D.G. Todd J.A. Nat. Genet. 2006; 38: 617-619Crossref PubMed Scopus (531) Google Scholar), exhibited complementing activity comparable with the wild type. However, E627* and I923V showed significantly low levels of activity. The phenotypes of these mutations were further tested by transient expression in MDA5–/– MEFs and monitoring endogenous IFN-β mRNA (Fig. 5B). Although MDA5 is absent, intracellular poly(I-C) induced IFN-β gene expression in the control cells (Vector). This is presumably due to the activation of RIG-I by a short poly(I-C) present in the preparation we used. Unlike the reporter assay, which monitors only transfected cells, this quantitative PCR assay detects IFN-β transcripts from both transfected and non-transfected cells, increasing the background signal. Irrespective of the background, overexpression of WT MDA5 resulted in an enhancement of IFN-β expression by poly(I-C), and this induction was not observed with E627* and I923V. Further, the effect was observed at different levels of MDA5 expression. The E627* mutant lacks a part of the helicase domain and the entire CTD in which Ile-923 resides.FIGURE 5Functional analysis of MDA5 nsSNP mutants. A, MDA5–/– MEFs were transfected with reporter genes together with the indicated constructs as in Fig. 2A. After stimulation with poly(I-C) (12 h), the cells were subjected to a Dual-Luciferase assay. Error bars show the S.D. values for triplicate transfections. mock, mock-treated. Vector, empty vector. B, MDA5–/– MEFs were transfected with expression vectors for WT MDA5 or E627* or Ile-923 mutants (the total amount of plasmid was kept at 6 μg by adding empty vector). To observe the dose response, cells were transfected with 3 or 5.7 μg of the expression plasmid. Cells were mock-treated or transfected with poly(I-C) for 12 h, and IFN-β mRNA was quantified by quantitative PCR as in Fig. 2C. C, 293T cells were transfected with empty vector, WT MDA5, E627*, I923V, or A946T, and the produced proteins were purified using anti-FLAG ("Experimental Procedures"). The purified proteins were separated by SDS-PAGE and stained by Coomassie Brilliant Blue. D, EMSA of the purified MDA5 proteins (500 ng) using 32P-labeled poly(I-C) as a probe. complex, probe protein complex; probe, free probe. E, dose response of RNA binding by WT MDA5 and the I923V mutant. EMSA was performed using 500, 300, and 100 ng of MDA5 and Ile-923 protein.View Large Image Figure ViewerDownload Hi-res image Download (PPT) Because in the case of RIG-I, the CTD determines RNA recognition specificity, we investigated the RNA binding activity of these mutants by EMSA using 32P-labeled poly(I-C). Wild-type and recombinant MDA5 proteins were expressed in 293T cells and purified. The recombinant proteins were virtually free of other cellular proteins as analyzed by Coomassie Brilliant Blue staining (Fig. 5C). Wild-type MDA5 clearly formed a complex with poly(I-C) (Fig. 5D), but E627* did not exhibit detectable binding activity. I923V and A946T exhibited activity to bind poly(I-C) as strongly as the wild type under these conditions. We further compared the RNA binding at different protein concentrations (Fig. 5E) and confirmed that MDA5 WT and the I923V mutant bind to dsRNA in a comparable fashion. These results suggest that the E627* mutant is biologically inactive due to its failure to recognize its agonist. Human RIG-I Polymorphism—We identified S183I as a loss of function mutation of RIG-I. This serine residue is conserved in human, monkey, cow, and pig RIG-I. The mutation apparently inactivates the tandem CARD, which relays signals downstream. Furthermore, S183I exhibits a dominant inhibitory phenotype, suggesting that individuals retaining this mutation as a heterozygote would exhibit hypersensitivity to viral infections. It has been shown that RIG-I mutants with a CARD deletion (RIG-IC), CARD point mutation (T55I), and ATP-binding site mutation (RIG-I K270A) all function as a dominant inhibitor (3Yoneyama M. Kikuchi M. Natsukawa T. Shinobu N. Imaizumi T. Miyagishi M. Taira K. Akira S. Fujita T. Nat. Immun. 2004; 5: 730-737Crossref Scopus (3121) Google Scholar, 7Saito T. Hirai R. Loo Y.M. Owen D. Johnson C.L. Sinha S.C. Akira S. Fujita T. Gale Jr., M. Proc. Natl. Acad. Sci. U. S. A. 2007; 104: 582-587Crossref PubMed Scopus (583) Google Scholar). It has been reported that the repression domain present in the C-terminal region of RIG-I and LGP2 dominantly suppresses the activation of RIG-I in trans through interaction with CARD and the helicase loop region (7Saito T. Hirai R. Loo Y.M. Owen D. Johnson C.L. Sinha S.C. Akira S. Fujita T. Gale Jr., M. Proc. Natl. Acad. Sci. U. S. A. 2007; 104: 582-587Crossref PubMed Scopus (583) Google Scholar). Because the repression domain encompasses the RNA-binding domain of RIG-I (6Takahasi K. Yoneyama M. Nishihori T. Hirai R. Kumeta H. Narita R. Gale Jr., M. Inagaki F. Fujita T. Mol. Cell. 2008; 29: 428-440Abstract Full Text Full Text PDF PubMed Scopus (392) Google Scholar), one mechanism is likely competition of RNA binding with WT RNA. However, the RNA binding-deficient RIG-I mutants, K888A/K907A and K858A/K861A (6Takahasi K. Yoneyama M. Nishihori T. Hirai R. Kumeta H. Narita R. Gale Jr., M. Inagaki F. Fujita T. Mol. Cell. 2008; 29: 428-440Abstract Full Text Full Text PDF PubMed Scopus (392) Google Scholar), functioned as a dominant negative inhibitor. 3J.-P. Zheng and T. Fujita, unpublished observation. Interestingly, LGP2 mutants, K643E and K651E, which correspond to Lys-888 and Lys-907 of RIG-I, lost RNA binding activity but retain repression function (17Li X. Ranjith-Kumar C.T. Brooks M.T. Dharmaiah S. Herr A.B. Kao C. Li P. J. Biol. Chem. March 28, 2009; 10.1074/jbc.M900818200Google Scholar). These results strongly suggest an RNA-independent mechanism. One proposed function of the second CARD is to conjugate to ubiquitin (at Lys-172), which may be essential for signaling activity. However, human RIG-I with K172R, which is resistant to ubiquitination, did not affect phenotype (Fig. 3, C and D). Moreover, the corresponding amino acid in mouse RIG-I is glutamine, and the corresponding position of MDA5 is glutamic acid (human, monkey, mouse, cow, and pig), suggesting that the ubiquitination of Lys-172 has a minor impact on signaling activity. The precise function of the second CARD is not clear, but a comparative study of Ser-183 and WT RIG-I will elucidate the molecular function of this residue. Human MDA5 Polymorphism—We identified two loss of function mutations, E627* and I923V, in human MDA5. Each of these mutations is actually present in the human population (13Nejentsev S. Walker N. Riches D. Egholm M. Todd J.A. Science. March 5, 2009; 10.1126/science.1167728PubMed Google Scholar). It is worth investigating the phenotype of the homozygote because MDA5 knock-out mice clearly exhibit hypersusceptibility to the family Picornaviridae, genus Cardiovirus. E627*, which lacks CTD and a part of the helicase domain, lost its dsRNA binding activity; hence there was no signaling activity. Although the I923V mutation occurs in the CTD, this mutant exhibited intact dsRNA binding, suggesting a novel function of Ile-923 other than the recognition of RNA. It is worth noting that this isoleucine is conserved in human, monkey, mouse, cow, and pig MDA5. It is tempting to speculate that Ile-923 participates in an interaction with some other domain of MDA5 or other unknown regulatory protein(s). A new report by Nejentsev et al. (13Nejentsev S. Walker N. Riches D. Egholm M. Todd J.A. Science. March 5, 2009; 10.1126/science.1167728PubMed Google Scholar) describing the relationship between susceptibility to T1D and MDA5 polymorphism was published. The report describes that four rare mutations (two mutations in the exon and two mutations in the intron) in the human MDA5 gene are associated with protection against T1D. Our analysis included the two exon mutations (E627* and I923V), which exhibited a loss of function phenotype. The genetic analysis included another rare nsSNP, H460R, shown to be independent of T1D resistance. The phenotype of this mutant was normal in our analysis. On the other hand, A946T, which was suggested to associate with T1D in previous reports (13Nejentsev S. Walker N. Riches D. Egholm M. Todd J.A. Science. March 5, 2009; 10.1126/science.1167728PubMed Google Scholar, 16Smyth D.J. Cooper J.D. Bailey R. Field S. Burren O. Smink L.J. Guja C. Ionescu-Tirgoviste C. Widmer B. Dunger D.B. Savage D.A. Walker N.M. Clayton D.G. Todd J.A. Nat. Genet. 2006; 38: 617-619Crossref PubMed Scopus (531) Google Scholar), did not exhibit a loss of function phenotype. However, because Nejentsev et al. (13Nejentsev S. Walker N. Riches D. Egholm M. Todd J.A. Science. March 5, 2009; 10.1126/science.1167728PubMed Google Scholar) suggested that the association of A946R with T1D was due to the effect of another nsSNP, R843H, a combination of these mutations might confer loss of function on MDA5. In summary, our analysis strongly suggests that loss of function mutations of MDA5 have a causative role in resistance to T1D. Although T1D has a complex pathology, these findings may provide a new strategy for establishing an animal model for T1D. The human genome encodes multiple sensors, including TLRs and RLRs for viral PAMPs. Some of these may act redundantly to secure defense against viral infections. In the case of RLRs, RIG-I and MDA5 detect a distinct spectrum of viruses, as suggested from the phenotype of respective knock-out mice. There is variation within human populations in susceptibility to a particular viral infection. We argue for a possible contribution of the genetic diversity of RLRs, including those identified in the current investigation, to susceptibility. In addition to the impact of the infection itself, secondary effects such as autoimmunity, which is remotely triggered by certain viral infections, may be influenced at least in part through the functional diversity of RLRs. In summary, our results suggest a critical relationship between RLR polymorphisms and diseases including viral infections and autoimmunity. We greatly appreciate the gift of MEFs from Dr. S. Akira (Research Institute for Microbial Diseases, Osaka University, Osaka). We give our thanks to Dr. F. Matsuda (Center for Genomic Medicine, Kyoto University, Kyoto) for discussion.
What problem does this paper attempt to address?
-
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Hiroki Kato,Osamu Takeuchi,Shintaro Sato,Mitsutoshi Yoneyama,Masahiro Yamamoto,Kosuke Matsui,Satoshi Uematsu,Andreas Jung,Taro Kawai,Ken J. Ishii,Osamu Yamaguchi,Kinya Otsu,Tohru Tsujimura,Chang-Sung Koh,Caetano Reis e Sousa,Yoshiharu Matsuura,Takashi Fujita,Shizuo Akira
DOI: https://doi.org/10.1038/nature04734
IF: 64.8
2006-04-09
Nature
Abstract:The innate immune system senses viral infection by recognizing a variety of viral components (including double-stranded (ds)RNA) and triggers antiviral responses1,2. The cytoplasmic helicase proteins RIG-I (retinoic-acid-inducible protein I, also known as Ddx58) and MDA5 (melanoma-differentiation-associated gene 5, also known as Ifih1 or Helicard) have been implicated in viral dsRNA recognition3,4,5,6,7. In vitro studies suggest that both RIG-I and MDA5 detect RNA viruses and polyinosine-polycytidylic acid (poly(I:C)), a synthetic dsRNA analogue3. Although a critical role for RIG-I in the recognition of several RNA viruses has been clarified8, the functional role of MDA5 and the relationship between these dsRNA detectors in vivo are yet to be determined. Here we use mice deficient in MDA5 (MDA5-/-) to show that MDA5 and RIG-I recognize different types of dsRNAs: MDA5 recognizes poly(I:C), and RIG-I detects in vitro transcribed dsRNAs. RNA viruses are also differentially recognized by RIG-I and MDA5. We find that RIG-I is essential for the production of interferons in response to RNA viruses including paramyxoviruses, influenza virus and Japanese encephalitis virus, whereas MDA5 is critical for picornavirus detection. Furthermore, RIG-I-/- and MDA5-/- mice are highly susceptible to infection with these respective RNA viruses compared to control mice. Together, our data show that RIG-I and MDA5 distinguish different RNA viruses and are critical for host antiviral responses.
multidisciplinary sciences
-
Accessory Factors of Cytoplasmic Viral RNA Sensors Required for Antiviral Innate Immune Response
Hiroyuki Oshiumi,Takahisa Kouwaki,Tsukasa Seya
DOI: https://doi.org/10.3389/fimmu.2016.00200
2016-05-25
Abstract:Type I interferon (IFN) induces many antiviral factors in host cells. RIG-I-like receptors (RLRs) are cytoplasmic viral RNA sensors that trigger the signal to induce the innate immune response that includes type I IFN production. RIG-I and MDA5 are RLRs that form nucleoprotein filaments along viral double-stranded RNA, resulting in the activation of MAVS adaptor molecule. The MAVS protein forms a prion-like aggregation structure, leading to type I IFN production. RIG-I and MDA5 undergo post-translational modification. TRIM25 and Riplet ubiquitin ligases deliver a K63-linked polyubiquitin moiety to the RIG-I N-terminal caspase activation and recruitment domains (CARDs) and C-terminal region; the polyubiquitin chain then stabilizes the two-CARD tetramer structure required for MAVS assembly. MDA5 activation is regulated by phosphorylation. RIOK3 is a protein kinase that phosphorylates the MDA5 protein in a steady state, and PP1α/γ dephosphorylate this protein, resulting in its activation. RIG-I and MDA5 require cytoplasmic RNA helicases for their efficient activation. LGP2, another RLR, is an RNA helicase involved in RLR signaling. This protein does not possess N-terminal CARDs and, thus, cannot trigger downstream signaling by itself. Recent studies have revealed that this protein modulates MDA5 filament formation, resulting in enhanced type I IFN production. Several other cytoplasmic RNA helicases are involved in RLR signaling. DDX3, DHX29, DHX36, and DDX60 RNA helicases have been reported to be involved in RLR-mediated type I IFN production after viral infection. However, the underlying mechanism is largely unknown. Future studies are required to reveal the role of RNA helicases in the RLR signaling pathway.
-
Kinetic discrimination of self/non-self RNA by the ATPase activity of RIG-I and MDA5
Jade Louber,Joanna Brunel,Emiko Uchikawa,Stephen Cusack,Denis Gerlier
DOI: https://doi.org/10.1186/s12915-015-0166-9
IF: 7.364
2015-07-28
BMC Biology
Abstract:BackgroundThe cytoplasmic RIG-like receptors are responsible for the early detection of viruses and other intracellular microbes by activating the innate immune response mediated by type I interferons (IFNs). RIG-I and MDA5 detect virus-specific RNA motifs with short 5′-tri/diphosphorylated, blunt-end double-stranded RNA (dsRNA) and >0.5–2 kb long dsRNA as canonical agonists, respectively. However, in vitro, they can bind to many RNA species, while in cells there is an activation threshold. As SF2 helicase/ATPase family members, ATP hydrolysis is dependent on co-operative RNA and ATP binding. Whereas simultaneous ATP and cognate RNA binding is sufficient to activate RIG-I by releasing autoinhibition of the signaling domains, the physiological role of the ATPase activity of RIG-I and MDA5 remains controversial.ResultsA cross-analysis of a rationally designed panel of RNA binding and ATPase mutants and truncated receptors, using type I IFN promoter activation as readout, allows us to refine our understanding of the structure-function relationships of RIG-I and MDA5. RNA activation of RIG-I depends on multiple critical RNA binding sites in its helicase domain as confirmed by functional evidence using novel mutations. We found that RIG-I or MDA5 mutants with low ATP hydrolysis activity exhibit constitutive activity but this was fully reverted when associated with mutations preventing RNA binding to the helicase domain. We propose that the turnover kinetics of the ATPase domain enables the discrimination of self/non-self RNA by both RIG-I and MDA5. Non-cognate, possibly self, RNA binding would lead to fast ATP turnover and RNA disassociation and thus insufficient time for the caspase activation and recruitment domains (CARDs) to promote downstream signaling, whereas tighter cognate RNA binding provides a longer time window for downstream events to be engaged.ConclusionsThe exquisite fine-tuning of RIG-I and MDA5 RNA-dependent ATPase activity coupled to CARD release allows a robust IFN response from a minor subset of non-self RNAs within a sea of cellular self RNAs. This avoids the eventuality of deleterious autoimmunity effects as have been recently described to arise from natural gain-of-function alleles of RIG-I and MDA5.
biology
-
MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells.
Qian Feng,Stanleyson V Hato,Martijn A Langereis,Jan Zoll,Richard Virgen-Slane,Alys Peisley,Sun Hur,Bert L Semler,Ronald P van Rij,Frank J M van Kuppeveld
DOI: https://doi.org/10.1016/j.celrep.2012.10.005
IF: 8.8
2012-01-01
Cell Reports
Abstract:RIG-I and MDA5 are cytosolic RNA sensors that play a critical role in innate antiviral responses. Major advances have been made in identifying RIG-I ligands, but our knowledge of the ligands for MDA5 remains restricted to data from transfection experiments mostly using poly(I:C), a synthetic dsRNA mimic. Here, we dissected the IFN-α/β-stimulatory activity of different viral RNA species produced during picornavirus infection, both by RNA transfection and in infected cells in which specific steps of viral RNA replication were inhibited. Our results show that the incoming genomic plus-strand RNA does not activate MDA5, but minus-strand RNA synthesis and production of the 7.5 kbp replicative form trigger a strong IFN-α/β response. IFN-α/β production does not rely on plus-strand RNA synthesis and thus generation of the partially double-stranded replicative intermediate. This study reports MDA5 activation by a natural RNA ligand under physiological conditions.
-
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses
Mitsutoshi Yoneyama,Mika Kikuchi,Takashi Natsukawa,Noriaki Shinobu,Tadaatsu Imaizumi,Makoto Miyagishi,Kazunari Taira,Shizuo Akira,Takashi Fujita
DOI: https://doi.org/10.1038/ni1087
IF: 30.5
2004-06-20
Nature Immunology
Abstract:Intracellular double-stranded RNA (dsRNA) is a chief sign of replication for many viruses. Host mechanisms detect the dsRNA and initiate antiviral responses. In this report, we identify retinoic acid inducible gene I (RIG-I), which encodes a DExD/H box RNA helicase that contains a caspase recruitment domain, as an essential regulator for dsRNA-induced signaling, as assessed by functional screening and assays. A helicase domain with intact ATPase activity was responsible for the dsRNA-mediated signaling. The caspase recruitment domain transmitted 'downstream' signals, resulting in the activation of transcription factors NF-κB and IRF-3. Subsequent gene activation by these factors induced antiviral functions, including type I interferon production. Thus, RIG-I is key in the detection and subsequent eradication of the replicating viral genomes.
immunology
-
The IFN‐inducible GTPase IRGB10 Regulates Viral Replication and Inflammasome Activation During Influenza A Virus Infection in Mice
Shelbi Christgen,David E. Place,Min Zheng,Benoit Briard,Masahiro Yamamoto,Thirumala-Devi Kanneganti
DOI: https://doi.org/10.1002/eji.202149305
2021-01-01
European Journal of Immunology
Abstract:The upregulation of interferon (IFN)-inducible GTPases in response to pathogenic insults is vital to host defense against many bacterial, fungal, and viral pathogens. Several IFN-inducible GTPases play key roles in mediating inflammasome activation and providing host protection after bacterial or fungal infections, though their role in inflammasome activation after viral infection is less clear. Among the IFN-inducible GTPases, the expression of immunity-related GTPases (IRGs) varies widely across species for unknown reasons. Here, we report that IRGB10, but not IRGM1, IRGM2, or IRGM3, is required for NLRP3 inflammasome activation in response to influenza A virus (IAV) infection in mice. While IRGB10 functions to release inflammasome ligands in the context of bacterial and fungal infections, we found that IRGB10 facilitates endosomal maturation and nuclear translocation of IAV, thereby regulating viral replication. Corresponding with our in vitro results, we found that Irgb10-/- mice were more resistant to IAV-induced mortality than WT mice. The results of our study demonstrate a detrimental role of IRGB10 in host immunity in response to IAV and a novel function of IRGB10, but not IRGMs, in promoting viral translocation into the nucleus.
-
RIG-I in RNA virus recognition
Alison M. Kell,Michael Gale
DOI: https://doi.org/10.1016/j.virol.2015.02.017
IF: 3.513
2015-05-01
Virology
Abstract:Antiviral immunity is initiated upon host recognition of viral products via non-self molecular patterns known as pathogen-associated molecular patterns (PAMPs). Such recognition initiates signaling cascades that induce intracellular innate immune defenses and an inflammatory response that facilitates development of the acquired immune response. The retinoic acid-inducible gene I (RIG-I) and the RIG-I-like receptor (RLR) protein family are key cytoplasmic pathogen recognition receptors that are implicated in the recognition of viruses across genera and virus families, including functioning as major sensors of RNA viruses, and promoting recognition of some DNA viruses. RIG-I, the charter member of the RLR family, is activated upon binding to PAMP RNA. Activated RIG-I signals by interacting with the adapter protein MAVS leading to a signaling cascade that activates the transcription factors IRF3 and NF-κB. These actions induce the expression of antiviral gene products and the production of type I and III interferons that lead to an antiviral state in the infected cell and surrounding tissue. RIG-I signaling is essential for the control of infection by many RNA viruses. Recently, RIG-I crosstalk with other pathogen recognition receptors and components of the inflammasome has been described. In this review, we discuss the current knowledge regarding the role of RIG-I in recognition of a variety of virus families and its role in programming the adaptive immune response through cross-talk with parallel arms of the innate immune system, including how RIG-I can be leveraged for antiviral therapy.
virology
-
RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses
Takahisa Kouwaki,Tasuku Nishimura,Guanming Wang,Hiroyuki Oshiumi
DOI: https://doi.org/10.3389/fimmu.2021.700926
2021-06-25
Abstract:RIG-I-like receptors (RLR), RIG-I and MDA5, are cytoplasmic viral RNA sensors that recognize viral double-stranded RNAs and trigger signals to induce antiviral responses, including type I interferon production. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) caused the coronavirus disease 2019 pandemic. However, the RLR role in innate immune response to SARS-CoV-2 has not been fully elucidated. Here, we studied the roles of RLR in cytokine expression responding to SARS-CoV-2 and found that not only MDA5 but also RIG-I are involved in innate immune responses in some types of human cells. Transfection of total RNAs extracted from SARS-CoV-2-infected cells into epithelial cells induced IFN-β, IP-10, and Ccl5 mRNA expression. The cytokine expression was reduced by knockout of either RIG-I or MDA5, suggesting that both proteins are required for appropriate innate immune response to SARS-CoV-2. Two viral genomic RNA regions strongly induced type I IFN expression, and a 200-base fragment of viral RNA preferentially induced type I IFN in a RIG-I-dependent manner. In contrast, SARS-CoV-2 infectious particles hardly induced cytokine expression, suggesting viral escape from the host response. Viral 9b protein inhibited RIG-I and MAVS interaction, and viral 7a protein destabilized the TBK1 protein, leading to attenuated IRF-3 phosphorylation required for type I IFN expression. Our data elucidated the mechanism underlying RLR-mediated response to SARS-CoV-2 infection and viral escape from the host innate immune response.
-
Virus Sensor RIG-I Represses RNA Interference by Interacting with TRBP through LGP2 in Mammalian Cells
Tomoko Takahashi,Yuko Nakano,Koji Onomoto,Mitsutoshi Yoneyama,Kumiko Ui-Tei
DOI: https://doi.org/10.3390/genes9100511
IF: 4.141
2018-10-19
Genes
Abstract:Exogenous double-stranded RNAs (dsRNAs) similar to viral RNAs induce antiviral RNA silencing or RNA interference (RNAi) in plants or invertebrates, whereas interferon (IFN) response is induced through activation of virus sensor proteins including Toll like receptor 3 (TLR3) or retinoic acid-inducible gene I (RIG-I) like receptors (RLRs) in mammalian cells. Both RNA silencing and IFN response are triggered by dsRNAs. However, the relationship between these two pathways has remained unclear. Laboratory of genetics and physiology 2 (LGP2) is one of the RLRs, but its function has remained unclear. Recently, we reported that LGP2 regulates endogenous microRNA-mediated RNA silencing by interacting with an RNA silencing enhancer, TAR-RNA binding protein (TRBP). Here, we investigated the contribution of other RLRs, RIG-I and melanoma-differentiation-associated gene 5 (MDA5), in the regulation of RNA silencing. We found that RIG-I, but not MDA5, also represses short hairpin RNA (shRNA)-induced RNAi by type-I IFN. Our finding suggests that RIG-I, but not MDA5, interacts with TRBP indirectly through LGP2 to function as an RNAi modulator in mammalian cells.
genetics & heredity
-
Retinoic acid inducible gene-I, more than a virus sensor
Feng Liu,Jun Gu
DOI: https://doi.org/10.1007/s13238-011-1045-y
2011-01-01
Protein & Cell
Abstract:Retinoic acid inducible gene-I (RIG-I) is a caspase recruitment domain (CARD) containing protein that acts as an intracellular RNA receptor and senses virus infection. After binding to double stranded RNA (dsRNA) or 5′-triphosphate single stranded RNA (ssRNA), RIG-I transforms into an open conformation, translocates onto mitochondria, and interacts with the downstream adaptor mitochondrial antiviral signaling (MAVS) to induce the production of type I interferon and inflammatory factors via IRF3/7 and NF-κB pathways, respectively. Recently, accumulating evidence suggests that RIG-I could function in non-viral systems and participate in a series of biological events, such as inflammation and inflammation related diseases, cell proliferation, apoptosis and even senescence. Here we review recent advances in antiviral study of RIG-I as well as the functions of RIG-I in other fields.
-
Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5
Stephanie Reikine,Jennifer B Nguyen,Yorgo Modis
DOI: https://doi.org/10.3389/fimmu.2014.00342
2014-07-23
Abstract:Most organisms rely on innate immune receptors to recognize conserved molecular structures from invading microbes. Two essential innate immune receptors, RIG-I and MDA5, detect viral double-stranded RNA in the cytoplasm. The inflammatory response triggered by these RIG-I-like receptors (RLRs) is one of the first and most important lines of defense against infection. RIG-I recognizes short RNA ligands with 5'-triphosphate caps. MDA5 recognizes long kilobase-scale genomic RNA and replication intermediates. Ligand binding induces conformational changes and oligomerization of RLRs that activate the signaling partner MAVS on the mitochondrial and peroxisomal membranes. This signaling process is under tight regulation, dependent on post-translational modifications of RIG-I and MDA5, and on regulatory proteins including unanchored ubiquitin chains and a third RLR, LGP2. Here, we review recent advances that have shifted the paradigm of RLR signaling away from the conventional linear signaling cascade. In the emerging RLR signaling model, large multimeric signaling platforms generate a highly cooperative, self-propagating, and context-dependent signal, which varies with the subcellular localization of the signaling platform.
-
Structural Basis of Double-Stranded RNA Recognition by the RIG-I Like Receptor MDA5.
Xiaojun Li,Cheng Lu,Mikaela Stewart,Hengyu Xu,Roland K. Strong,Tatyana Igumenova,Pingwei Li
DOI: https://doi.org/10.1016/j.abb.2009.06.008
IF: 4.114
2009-01-01
Archives of Biochemistry and Biophysics
Abstract:RIG-I, MDA5 and LGP2 are cytosolic pattern recognition receptors detecting single-stranded or double-stranded RNA in virally infected cells. The activation of RIG-I or MDA5 stimulates the secretion of type I interferons that play key roles in antiviral immune responses. The C-terminal domains (CTD) of RIG-I and LGP2 are responsible for RNA binding; however, it is not clear how MDA5 binds RNA. To understand the structural basis of dsRNA recognition by MDA5, we have determined the 1.45A resolution structure of the C-terminal domain of human MDA5. The structure revealed a highly conserved fold similar to the structures of RIG-I and LGP2 CTDs. NMR titration of MDA5 CTD with dsRNA demonstrated that a positively charged surface is involved in dsRNA binding. Mutagenesis and RNA binding studies showed that electrostatic interactions play primary roles in dsRNA recognition by MDA5. Like RIG-I and LGP2, MDA5 CTD preferentially binds dsRNA with blunt ends, but does not associate with dsRNA with either 5' or 3' overhangs. Molecular modeling of MDA5 CTD/dsRNA complex suggests that MDA5 CTD may recognize the first turn of blunt-ended dsRNA in a similar manner as LGP2.
-
Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5
Morgan Brisse,Hinh Ly
DOI: https://doi.org/10.3389/fimmu.2019.01586
IF: 7.3
2019-07-17
Frontiers in Immunology
Abstract:RIG-I (Retinoic acid-inducible gene I) and MDA5 (Melanoma Differentiation-Associated protein 5), collectively known as the RIG-I-like receptors (RLRs), are key protein sensors of the pathogen-associated molecular patterns (PAMPs) in the form of viral double-stranded RNA (dsRNA) motifs to induce expression of type 1 interferons (IFN1) (IFNα and IFNβ) and other pro-inflammatory cytokines during the early stage of viral infection. While RIG-I and MDA5 share many genetic, structural and functional similarities, there is increasing evidence that they can have significantly different strategies to recognize different pathogens, PAMPs, and in different host species. This review article discusses the similarities and differences between RIG-I and MDA5 from multiple perspectives, including their structures, evolution and functional relationships with other cellular proteins, their differential mechanisms of distinguishing between host and viral dsRNAs and interactions with host and viral protein factors, and their immunogenic signaling. A comprehensive comparative analysis can help inform future studies of RIG-I and MDA5 in order to fully understand their functions in order to optimize potential therapeutic approaches targeting them.
immunology
-
MDA5 ISGylation is crucial for immune signaling to control viral replication and pathogenesis
Lucky Sarkar,GuanQun Liu,Dhiraj Acharya,Junji Zhu,Zuberwasim Sayyad,Michaela Gack
DOI: https://doi.org/10.1101/2024.09.20.614144
2024-09-24
Abstract:The posttranslational modification (PTM) of innate immune sensor proteins by ubiquitin or ubiquitin-like proteins is crucial for regulating antiviral host responses. The cytoplasmic dsRNA receptor melanoma differentiation-associated protein 5 (MDA5) undergoes several PTMs including ISGylation within its first caspase activation and recruitment domain (CARD), which promotes MDA5 signaling. However, the relevance of MDA5 ISGylation for antiviral immunity in an infected organism has been elusive. Here, we generated knock-in mice (MDA5K23R/K43R) in which the two major ISGylation sites, K23 and K43, in MDA5 were mutated. Primary cells derived from MDA5K23R/K43R mice exhibited abrogated endogenous MDA5 ISGylation and an impaired ability of MDA5 to form oligomeric assemblies leading to blunted cytokine responses to MDA5 RNA-agonist stimulation or infection with encephalomyocarditis virus (EMCV) or West Nile virus. Phenocopying MDA5−/− mice, the MDA5K23R/K43R mice infected with EMCV displayed increased mortality, elevated viral titers, and an ablated induction of cytokines and chemokines compared to WT mice. Molecular studies identified human HERC5 (and its functional murine homolog HERC6) as the primary E3 ligases responsible for MDA5 ISGylation and activation. Taken together, these findings establish the importance of CARD ISGylation for MDA5-mediated RNA virus restriction, promoting potential avenues for immunomodulatory drug design for antiviral or anti-inflammatory applications.
Immunology
-
Regulation of Interferon Production by RIG-I and LGP2: A Lesson in Self-Control
Damien Vitour,Eliane F. Meurs
DOI: https://doi.org/10.1126/stke.3842007pe20
2007-05-01
Abstract:The cytoplasmic CARD-containing DExD/H box RNA helicases RIG-I and MDA5 act as sensors of viral infections through recognition of viral double-stranded (ds) RNAs. They both associate with the mitochondrial adaptor IPS-1 (also referred to as MAVS, VISA, and CARDIF) through homotypic CARD-CARD interactions. IPS-1, in turn, triggers signaling pathways, including activation of the protein kinases TBK1 and IKKε, responsible for the phosphorylation of IRF3, a key transcription factor involved in interferon (IFN) synthesis, one essential element of the innate immune response. RIG-I remains in an autoinhibited state in the absence of dsRNA, through an internal repressor domain (RD) that binds within both its CARD and its RNA helicase domains and therefore acts in cis to control its multimerization and interaction with IPS-1. Ectopic expression of the RD prevents signaling and increases cell permissiveness to viruses, including hepatitis C virus. LGP2, which is another DExD/H RNA helicase of the RIG-I and MDA5 family and which is devoid of CARD domain, negatively controls IFN induction at different levels: by sequestering dsRNA, by blocking RIG-I’s multimerization in trans through a domain analogous to the RIG-I RD, and by competing with the protein kinase IKKε for a common interaction site on IPS-1. The ability of RIG-I and LGP2 to exert such a feedback control at the earliest steps of IFN synthesis allows the cells to exert a tight regulation of the induction of the innate immune response.
-
Helicase protein DDX11 as a novel antiviral factor promoting RIG-I-MAVS-mediated signaling pathway
Jiyu Zhang,Liaoyuan Zhang,Dakai Liu,Hongyan Shi,Xin Zhang,Jianfei Chen,Xiaoman Yang,Miaomiao Zeng,Jialin Zhang,Tingshuai Feng,Xiaoyuan Zhu,Zhaoyang Jing,Zhaoyang Ji,Da Shi,Li Feng
DOI: https://doi.org/10.1128/mbio.02028-24
IF: 6.4
2024-10-30
mBio
Abstract:ABSTRACT Type Ι interferon (IFN) production mediated by retinoic acid-inducible gene 1 (RIG-I) and mitochondrial antiviral signaling protein (MAVS) is essential for antiviral innate immune responses. Here, we report the identification of a novel co-sensor for cytosolic nucleic acids: DEAD/H-box helicase 11 (DDX11), a member of the DExD/H (Asp-Glu-x-Asp/His)-box helicase family. Knockdown or knockout of DDX11 attenuated the ability of cells to increase IFN-β, IFN-stimulated gene 56, and C-X-C motif chemokine ligand 10 in response to SeV and poly (I:C) by blocking the activation of TANK-binding kinase 1 and IFN regulatory factor 3. Nucleic acid sensing by DDX11 was independent of the stimulator of IFN genes but was dependent on RIG-I and MAVS. DDX11 regulated RIG-I-MAVS-mediated IFN signaling by specifically interacting with nucleic acid, RIG-I, and MAVS to enhance RIG-I-double-strand RNA and RIG-I-MAVS binding affinity. Overall, our results identified a critical role for DDX11 in the innate immune response and provided molecular insights into the mechanisms by which DDX11 recognized cytosolic nucleic acid and interacted with RIG-Ι and MAVS for potent IFN signaling and antiviral immunity. IMPORTANCE Innate immunity is the first and most rapid host defense against virus infection. Recognition of viral RNA by the retinoic acid-inducible gene 1 (RIG-I)-like receptors (RLRs) initiates innate antiviral immune responses. How the binding of viral RNA to and activation of the RLRs are regulated remains enigmatic. In this study, we identified DEAD/H-box helicase 11 (DDX11) as a positive regulator of the RIG-I-mitochondrial antiviral signaling protein (MAVS)-mediated signaling pathways. Mechanistically, we demonstrated that DDX11 bound to viral RNA, interacted with RIG-I, and promoted their binding to viral RNA. DDX11 also promoted the interaction between RIG-I and MAVS and activation of RIG-I-MAVS signaling. Overall, our results elucidate the role of DDX11 in RIG-I-MAVS-dependent signaling pathways and may shed light on innate immune gene regulation.
microbiology
-
Structures of RIG-I-Like Receptors and Insights into Viral RNA Sensing.
Xiaojiao Fan,Tengchuan Jin
DOI: https://doi.org/10.1007/978-981-13-9367-9_8
2019-01-01
Abstract:RIG-I-like receptors (RLRs) are an important family of pattern recognition receptors. They activate the immunological responses against viral infections by sensing RNAs in the cytoplasm. Recent studies provide significant insights into the activation and transduction mechanisms of RLRs family (members including RIG-I, MDA5, and LGP2). Here we review our current understanding of the structures of RLRs. Structural characterizations of RLRs family have revealed the mechanism of their actions at molecular level. The activation mechanisms of RIG-I and MDA5 are different, despite both of them have similar domain organizations and bind to dsRNA ligands. RIG-I, but not MDA5, adopts an auto-suppression conformation in the absence of RNA. In addition to ligand triggered receptor oligomerization, the activities of these receptors are also regulated by several posttranslational modifications, especially ubiquitination. Overall, these structural studies play critical roles in promoting the understanding of viral RNA recognition mechanisms by the host innate immune system, which also contribute to the designing of drugs for treatment of viral infection. However, much work remains to be done in studying the signaling pathway of MDA5 and LGP2, particularly by structural biology.
-
Structural and Mechanistic Basis for Self Versus Non‐self RNA Discrimination by the Innate Immune Receptor RIG‐I
Swapnil Devarkar,Chen Wang,Anand Ramanathan,Fuguo Jiang,Matthew Miller,Abdul Khan,Joseph Marcotrigiano,Smita Patel
DOI: https://doi.org/10.1096/fasebj.30.1_supplement.592.3
2016-01-01
The FASEB Journal
Abstract:RNAs with 5′‐triphosphate (ppp) are detected in the cytoplasm principally by the innate immune receptor RIG‐I, whose activation triggers a Type I interferon response. Cellular RNAs undergo post‐transcriptional modifications which ensures that self RNAs do not carry 5′ppp and/or blunt‐ends. We carried out a thorough biochemical characterization of RIG‐I complexes with RNAs carrying various end‐modifications as well as measured the effect of these end‐modifications on their signaling activity. We find that discrimination of RNA ligands occurs at multiple stages and signaling RNAs have high affinity and ATPase turnover rate and thus a high k atpase / K d . Our studies reveal that the autoinhibitory interface between CARD2 (second CARD) and Hel2i (Helicase 2 insertion domain) plays a critical role in RNA selectivity, wherein this interface acts as a “gate” that prevents cellular RNAs from generating productive complexes that can signal. It is thought that self RNAs like mRNAs are not recognized by RIG‐I because 5′ppp is capped by the addition of a 7‐methyl guanosine (m7G) (Cap‐0) and the 5′‐end nucleotide ribose is 2′‐O‐methylated (Cap‐1). We provide a structural and mechanistic basis for the exact roles of capping and 2′‐O‐methylation in evading RIG‐I recognition using enzymatic assays, X‐ray crystallography and cell‐based signaling studies. Surprisingly, we find that Cap‐0 and 5′ppp dsRNA have similar binding affinities, activate RIG‐I's ATPase to the same extent, and shows the same cellular signaling response. Three new crystal structures of RIG‐I complexes with dsRNA bearing 5′OH, 5′ppp, and 5′Cap‐0 reveal that RIG‐I accommodates m7G in a cavity created through conformational changes in helicase‐motif IVa without perturbing the triphosphate interactions. In contrast, Cap‐1 modifications abrogate RIG‐I signaling through a mechanism involving the H830 residue, wherein 2′‐O‐methylation works synergistically with m7G capping to weaken RNA affinity and ATPase activity. Our work provides new structural insights into the host and viral immune evasive mechanisms from RIG‐I explaining the complexity of cap structures over evolution. Support or Funding Information This work was supported by NIH grant GM111959 to Joseph Marcotrigiano and Smita S Patel.
-
RIG-I-like receptor DRH-1 signals via CARDs to activate anti-viral immunity in intestinal cells
Lakshmi E. Batachari,Alyssa Y. Dai,Emily R. Troemel
DOI: https://doi.org/10.1101/2024.02.05.578694
2024-02-08
Abstract:Upon sensing viral RNA, mammalian RIG-I-like receptors activate downstream signals using caspase activation and recruitment domains (CARDs), which ultimately promote transcriptional immune responses that have been well-studied. In contrast, the downstream signaling mechanisms for invertebrate RIG-I-like receptors are much less clear. For example, the RIG-I-like receptor DRH-1 lacks annotated CARDs and upregulates the distinct output of RNA interference (RNAi). Here we found that, similar to mammal RIG-I-like receptors, DRH-1 signals through two tandem caspase activation and recruitment domains (2CARD) to induce a transcriptional immune response. Expression of DRH-1(2CARD) alone in the intestine was sufficient to induce immune gene expression, increase viral resistance, and promote thermotolerance, a phenotype previously associated with immune activation. We also found that DRH-1 is required in the intestine to induce immune gene expression, and we demonstrate subcellular colocalization of DRH-1 puncta with double-stranded RNA inside the cytoplasm of intestinal cells upon viral infection. Altogether, our results reveal mechanistic and spatial insights into anti-viral signaling in highlighting unexpected parallels in RIG-I-like receptor signaling between and mammals.
Immunology
-
The RIG-I-like Receptor LGP2 Recognizes the Termini of Double-stranded RNA
Xiaojun Li,C. T. Ranjith-Kumar,Monica T. Brooks,S. Dharmaiah,Andrew B. Herr,Cheng Kao,Pingwei Li
DOI: https://doi.org/10.1074/jbc.m900818200
IF: 5.485
2009-01-01
Journal of Biological Chemistry
Abstract:The RIG-I-like receptors (RLRs), RIG-I and MDA5, recognize single-stranded RNA with 5' triphosphates and double-stranded RNA (dsRNA) to initiate innate antiviral immune responses. LGP2, a homolog of RIG-I and MDA5 that lacks signaling capability, regulates the signaling of the RLRs. To establish the structural basis of dsRNA recognition by the RLRs, we have determined the 2.0-A resolution crystal structure of human LGP2 C-terminal domain bound to an 8-bp dsRNA. Two LGP2 C-terminal domain molecules bind to the termini of dsRNA with minimal contacts between the protein molecules. Gel filtration chromatography and analytical ultracentrifugation demonstrated that LGP2 binds blunt-ended dsRNA of different lengths, forming complexes with 2: 1 stoichiometry. dsRNA with protruding termini bind LGP2 and RIG-I weakly and do not stimulate the activation of RIG-I efficiently in cells. Surprisingly, full-length LGP2 containing mutations that abolish dsRNA binding retained the ability to inhibit RIG-I signaling.